Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05951179
Title Dose Expansion, Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-2)
Acronym ADVANCED-2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Protara Therapeutics
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.